Valuation: OptimizeRx Corporation

Market Cap 176M 158M 146M 132M 247M 16.81B 251M 1.74B 694M 8.8B 662M 648M 27.86B P/E 2026 *
42x
P/E 2027 * 21.5x
Enterprise Value 176M 158M 146M 132M 247M 16.81B 251M 1.74B 694M 8.8B 662M 648M 27.86B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.66x
Free-Float
78.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.97%
1 week-0.11%
Current month+9.46%
1 month+9.46%
3 months+45.77%
6 months+46.71%
Current year-25.45%
1 week 8.93
Extreme 8.93
9.47
1 month 8.11
Extreme 8.11
9.6
Current year 4.54
Extreme 4.54
14.16
1 year 4.54
Extreme 4.54
21.09
3 years 3.78
Extreme 3.78
22.25
5 years 3.78
Extreme 3.78
98.57
10 years 1.89
Extreme 1.890018
99.18
Manager TitleAgeSince
Chief Executive Officer 48 2024-12-30
Director of Finance/CFO 60 2021-10-10
Chief Operating Officer - 2025-08-17
Director TitleAgeSince
Director/Board Member 61 2017-01-11
Chairman 70 2024-01-23
Director/Board Member 70 2018-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Tax

Investor Relations Manager

-414 0.0022%
9/1/26 Tax

Investor Relations Manager

-1,432 0.0076%
8/21/26 Tax

Investor Relations Manager

-1,243 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-0.11%-53.39%+17.33% 176M
-0.29%-12.02%+0.08%+126.34% 3,481B
-0.25%-2.93%-6.41%+106.09% 1,596B
+0.00%+2.17%+15.08%+71.08% 557B
+1.59%+0.31%-40.53%+31.01% 433B
+0.55%-5.25%-42.71%+52.14% 255B
-0.70%-0.76%-43.15%+18.93% 247B
-6.23%-7.45%-10.07%+232.74% 215B
-0.65%-2.22%-32.41%+52.63% 134B
+5.37%+0.42%-10.66%+260.65% 115B
Average -0.24%-3.41%-22.42%+96.90% 703.3B
Weighted average by Cap. -0.22%-7.61%-6.88%+109.06%

Financials

2026 *2027 *
Net sales 96.23M 86.19M 79.52M 71.96M 135M 9.16B 137M 949M 378M 4.8B 361M 353M 15.19B 107M 95.48M 88.08M 79.71M 149M 10.15B 151M 1.05B 419M 5.31B 400M 392M 16.83B
Net income 4.92M 4.4M 4.06M 3.68M 6.87M 468M 6.98M 48.46M 19.33M 245M 18.45M 18.06M 776M 8.9M 7.98M 7.36M 6.66M 12.45M 848M 12.65M 87.78M 35.02M 444M 33.42M 32.7M 1.41B
Net Debt - -
Projected Income Statement - Annual - OptimizeRx Corporation
Logo OptimizeRx Corporation
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Employees
133
Date Price Change Volume
26-10-30 US$9.140 -2.45% 33,003
26-10-29 US$9.370 +0.75% 100,511
26-10-28 US$9.300 +2.65% 97,170
26-10-27 US$9.060 -0.11% 107,032
26-10-26 US$9.070 -0.87% 141,836
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OptimizeRx Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.370USD
Average target price
12.60USD
Spread / Average Target
+34.47%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OptimizeRx Corporation
  1. Stock Market
  2. Stocks
  3. OPRX Stock